Tag Archives: Weekly News

Healthcare stories making news this week

A group of physicians, educators and behavioral scientists say a team approach is essential if there is to be any hope of stemming an expected onslaught of diabetes as a result of the growing incidence of poorly controlled blood glucose levels. Nearly 21 million people in the United States, or 7% of the population, have diabetes, and many of them don’t even know it, according to a new data analysis by the Centers for Disease Control and Prevention. ”There’s a tidal wave headed our way, and we’re ignoring it,” said S. Sethu K. Reddy, MD, chair and program director for Cleveland Clinic’s Dept. of Endocrinology, Diabetes and Metabolism. Dr. Reddy, a roundtable member, spoke at the briefing. Continue reading

Weekend healthcare marketing news stories

Even though you may not be ready to take the plunge into social media you can still reserve you Facebook brand page.  Owning your Name, a Practice’s Facebook Page. Like domain names facebook titles are valuable commodities. Think about having your unique Facebook, Twitter and other names reserved even if you are not ready to make the plunge.  Even if you do not use it, it can become very valuable if another practice or business wants the name, later.  More news stories—-> Continue reading

Another week and lot’s of healthcare marketing and patient stories

“Shame on you”: an emerging pharma social media crisis. Social media: When patients fight back. The launch of a Facebook page by pregnant mothers in the USA angry about KV Pharmaceuticals’ pricing of its newly FDA-approved synthetic progesterone product, Makena, raises once again the urgent need for pharmaceutical companies to plan ahead for social media engagement. More stories you need to read here—-> Continue reading

Summary of healthcare news Week ending 02/18/11

FDA device chief: More review funding needed.  The U.S. Food and Drug Administration needs more funding to help discourage staff turnover and help speed reviews, the agency’s device chief said on Thursday.  FDA reviewers are stretched thin with a heavy workload and increasingly complex technologies to evaluate, Dr. Jeffrey Shuren told lawmakers at a hearing on device regulation’s impact on jobs and patients. Continue reading